QualitecFarma®’s Growth Plan Continues

QualitecFarma® welcomes its new branch office in the US, with different initiatives as part of its growth, including projects in various therapeutical areas, and a redesigned website also in place. 

Part of those initiatives involve different projects including paediatric studies in oncology such as, Malignant Glioma amongst other advanced solid tumours. It is a fast-progressing pathology with no new safe treatments in the last 17 years. Glioblastoma is such a complicated pathology, that only a few biotech companies dedicate their efforts to investigate it. Therefore, this new endeavour by the company is vital in playing its role to combat the disease. 

QualitecFarma®, a CRO with headquarters in Madrid, Spain is thrilled to announce the launch of its new look, www.qualitecfarma.com. The company is remodelling its website to provide a clear, modern, and user-friendly platform that reflects its philosophy. 

The site now features all available quality solutions, with easily accessible information from clinical trials, quality assurance, pharmacovigilance, to regulatory affairs and market access.

“We cordially invite everyone to explore the website and discover what we have to offer. We hope they enjoy the new features, a more interactive interface on the Home Page, and videos from part of the team sharing their experiences and passion working in drug development,” Oscar Mesa, CEO.